Aytu Biopharma (AYTU) Free Cash Flow (2010 - 2026)

Aytu Biopharma (AYTU) has 17 years of Free Cash Flow data on file, last reported at -$4.2 million in Q1 2026.

• On a quarterly basis, Free Cash Flow rose 35.9% year-over-year to -$4.2 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 127.09% increase from a year earlier, with the FY2025 full-year figure at -$2.2 million, down 26.09% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$4.2 million, down from $3.7 million in the prior quarter.
• Over the last five years, Free Cash Flow for AYTU reached as high as $9.4 million in Q2 2023 and fell as low as -$9.1 million in Q1 2022.
• Historically, Free Cash Flow has averaged -$1.6 million across 5 years, with a median of -$1.1 million in 2024.
• Across the five-year window, Free Cash Flow soared 2247.41% in 2024 and sank 2468.5% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$2.5 million in 2022, then jumped by 94.57% to -$135000.0 in 2023, then surged by 2247.41% to $2.9 million in 2024, then grew by 26.18% to $3.7 million in 2025, then plunged by 214.32% to -$4.2 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$4.2 million in Q1 2026, $3.7 million in Q4 2025, and -$618000.0 in Q3 2025.